Food & Function · 2020 · 22 citations · 31 references
MedicineNeurosciencePharmacologyMemoryMolecular NeuroscienceNeuropharmacologyCholinergic NeurochemistryCholinergic PharmacologyMemory DisordersNeural Basis Of MemoryNeuroprotectionNeuroprotective PharmacologyAcetylcholinesterase FunctionAcetylcholinesterase InhibitorsAcetylcholinesterase TargetsAche InhibitionCholinergic Modulation Of MemoryCognitive Enhancement By Cholinergic AgentsMolecular Docking AnalysisRodent Memory
) showed improvement and a significant difference compared to those in the control group (P < 0.05, 0.01, or 0.001) in a passive avoidance test and in a water maze probe test. The brain extracts of the mice in the DC or donepezil group showed reduced AChE activities and higher ORAC activities and also showed a significant difference compared to those in the control group (P < 0.05, 0.01, or 0.001). DC might be beneficial for developing functional foods or as a lead compound for the treatment of degenerative disorders.
31
Acetylcholinesterase Inhibitors: Pharmacology and Toxicology
Mirjana B. Čolović, Danijela Krstić, Tamara Lazarević‐Pašti et al. · Current Neuropharmacology · 2013 · 2.5K citations · Full text
Medicine, Pharmacology, Toxicology +17